Importantly, IDO inhibitors have been suggested in basic cancer studies as novel and therapeutic (Muller et al., 2005) and recently, in studies on human cancer cells 1-D-MT has been confirmed to have beneficial properties (Opitz et al., 2011), the possibility of its use in the treatment of neuropathic pain needs to be studied. Here, IDO1 is linked to cancer.